York Haven, PA, United States of America

Lois Mary Witters


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 114(Granted Patents)


Company Filing History:


Years Active: 1999-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Lois Mary Witters**

Introduction

Lois Mary Witters, based in York Haven, PA, has made significant contributions to the field of pharmaceuticals with a specific focus on treating malignancies. With a total of four patents to her name, her innovative work has paved the way for advancements in medical treatments.

Latest Patents

Among her latest patents, one notable invention is a pharmaceutical composition for the treatment of malignancies. This composition combines bisphosphonates, a COX-2 inhibitor, and a taxol or its derivative, aimed at addressing malignant diseases associated with bone metastases or excessive bone resorption. The patent outlines methods for treating patients by administering these components effectively.

Another significant patent involves the inhibition of epidermal growth factor receptor (EGFR) expression. The composition includes oligonucleotides that are complementary to the mRNA of EGFR. The methods described enable the inhibition of EGFR expression, providing a potential treatment for cancers related to EGFR overexpression.

Career Highlights

Lois Mary Witters has had an impactful career, including positions at esteemed organizations such as the Penn State Research Foundation and Isis Pharmaceuticals, Inc. Her expertise in pharmaceutical development has contributed to her successful patent portfolio.

Collaborations

Throughout her career, Witters has collaborated with notable individuals in the industry, including Allan Lipton and C. Frank Bennett. These collaborations have further enriched her research and development efforts, enhancing the quality and impact of her inventions.

Conclusion

Lois Mary Witters stands out as an innovative inventor whose work has significantly influenced pharmaceutical treatments for cancer. Her patents highlight her expertise and commitment to advancing medical science, underscoring the importance of her contributions to the field. The ongoing impact of her inventions continues to hold promise for improved patient outcomes in the treatment of malignancies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…